Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load-Reference-Cited by-同舟云学术

Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

Published:2005 Issue:1 Volume:78 Page:83-90
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Akuta Norio,Suzuki Fumitaka,Sezaki Hitomi,Suzuki Yoshiyuki,Hosaka Tetsuya,Someya Takashi,Kobayashi Masahiro,Saitoh Satoshi,Watahiki Sachiyo,Sato Junko,Kobayashi Mariko,Arase Yasuji,Ikeda Kenji,Kumada Hiromitsu

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference29 articles.

1. Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors

2. Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy

3. Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival

4. Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

5. Suppressors of cytokine signalling (SOCS) in the immune system

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C;Clinical and Experimental Medicine;2024-08-08

2. Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator;Tzu Chi Medical Journal;2021

3. Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4;The American Journal of the Medical Sciences;2018-05

4. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma;Journal of Biosciences;2017-07-05

5. New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir;Journal of Gastroenterology;2017-01-11